成纤维细胞刺激脂肽-1作为潜在黏膜佐剂增强肠道病毒71型疫苗的黏膜和全身免疫应答
研究用BALB/c小鼠经鼻免疫EV71疫苗,比较FSL-1与Pam3CSK4两种TLR配体佐剂效果;EV71+FSL-1组血清、鼻洗液、支气管肺泡灌洗液和粪便中EV71特异性IgG和IgA显著高于EV71+Pam3CSK4组、EV71单独组和PBS对照组,且诱导更多抗体分泌细胞、T细胞增殖及干扰素-γ和白细胞介素-17分泌,血清可中和C2基因型并交叉中和B4和B5基因型。
要点
- EV71+FSL-1组血清、鼻洗液、支气管肺泡灌洗液和粪便中EV71特异性IgG和IgA显著高于EV71+Pam3CSK4组、EV71单独组和PBS对照组。
- FSL-1配方诱导更多EV71特异性IgG和IgA分泌细胞,并显著增加T细胞增殖反应及干扰素-γ和白细胞介素-17分泌。
- 免疫小鼠血清可中和EV71 C2基因型,并能交叉中和B4和B5基因型。
核心结论
- 数据提示FSL-1可作为鼻内EV71疫苗免疫的有效佐剂。
研究设计与样本
- 使用未免疫BALB/c小鼠,以3周间隔经鼻免疫3次。
主要发现
- EV71+FSL-1组血清、鼻洗液、支气管肺泡灌洗液和粪便中EV71特异性IgG和IgA显著高于EV71+Pam3CSK4组、EV71单独组和PBS对照组。
- 使用FSL-1配方的处理中观察到更多EV71特异性IgG和IgA分泌细胞。
- 灭活EV71以FSL-1配方时,T细胞增殖反应及干扰素-γ和白细胞介素-17分泌显著增加。
- 免疫小鼠血清能中和EV71 C2基因型,并能交叉中和B4和B5基因型。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
To prevent viral infection at the site of entry, mucosal vaccines are potent tools for inducing IgA secretion for defense. Because Toll-like receptor (TLR) ligands serve as strong adjuvants, two ligands that mimic the structure of mycoplasmal and bacterial lipopeptides represent interesting vaccine candidates. Pam3CSK4, a synthetic triacylated lipopeptide, interacts with TLR2/1. Because fibroblast-stimulating lipopeptide-1 (FSL-1), a synthetic diacylated lipopeptide, is recognized by TLR2/6, we targeted the potential immuno-inducibility of Pam3CSK4 and FSL-1 as adjuvants of an enterovirus 71 (EV71) mucosal vaccine. Naïve BALB/c mice were used for intranasal immunization three times over a 3-week interval, with results showing that EV71-specific IgG and IgA in serum, nasal washes, bronchoalveolar lavage fluid, and feces from the EV71 + FSL-1 group were significantly higher than levels observed in mice treated with EV71 + Pam3CSK4, EV71 alone, or the control group treated with phosphate-buffered saline. Furthermore, we observed more EV71-specific IgG and IgA-producing cells in treatments using EV71 formulated with FSL-1. Additionally, T cell-proliferative responses and interferon-γ and interleukin-17 secretion were significantly increased when inactivated EV71 was formulated using FSL-1. Moreover, serum from immunized mice was capable of neutralizing the infectivity of EV71 (C2 genotype) and was able to cross-neutralize the B4 and B5 genotypes of EV71. Our data suggested that FSL-1 could be used as an efficient adjuvant for intranasal EV71-vaccine immunization.
引用
- Lin YL, Cheng PY, Chin CL, et al. Fibroblast-stimulating lipopeptide-1 as a potential mucosal adjuvant enhances mucosal and systemic immune responses to enterovirus 71 vaccine. Vaccine. 2018. PMID: 29891349. doi:10.1016/j.vaccine.2018.05.090
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。